HOBSCOTCH Phase III
NCT04519775 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2025-07-01
Summary
The purpose of this study is to determine the efficacy of an entirely virtual version of the home-based cognitive self-management program "HOBSCOTCH." It will test whether HOBSCOTCH can be delivered nationally from a distance utilizing e-health tools (telephone, computer, and phone).
Conditions
Interventions
- BEHAVIORAL
-
Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH)
HOBSCOTCH is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life.
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
Dartmouth-Hitchcock Medical Center
lead OTHER
Principal Investigators
-
Barbara Jobst, MD · Dartmouth-Hitchcock Medical Center and Dartmouth College
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-12
- Primary Completion
- 2024-09-26
- Completion
- 2024-11-19
Countries
- United States
Study Locations
More Related Trials
-
Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease
NCT03252535 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
NCT05358717 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations
NCT03670953 ·Status: COMPLETED ·Phase: PHASE3
-
SHARPEN - Parkinson's Disease Dementia
NCT05987540 ·Status: TERMINATED ·Phase: NA
-
A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01970098 ·Status: COMPLETED ·Phase: PHASE3
-
2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD
NCT00209508 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment
NCT03713957 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)
NCT04928287 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations
NCT03877510 ·Status: COMPLETED ·Phase: PHASE3
-
Helicobacter Pylori Eradication Study in Parkinson's Disease
NCT02108704 ·Status: COMPLETED ·Phase: NA
-
Study of UB-312 in Healthy Participants and Parkinson's Disease Patients
NCT04075318 ·Status: COMPLETED ·Phase: PHASE1
-
Intermediate Size Expanded Access Protocol Using Autologous HB-adMSCs for the Treatment of Parkinson's Disease
NCT06056427 ·Status: NO_LONGER_AVAILABLE
-
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
NCT06976268 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01384435 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease
NCT06175767 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT02889302 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease
NCT04387773 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
NCT00387270 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease
NCT00228150 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease
NCT02074410 ·Status: TERMINATED ·Phase: PHASE2
-
Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease
NCT00195143 ·Status: COMPLETED ·Phase: PHASE1
-
PF 06412562 in Subjects With Advanced Stage Parkinson's Disease
NCT03665454 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy
NCT00407212 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety on SOM3355 in Huntington's Disease Chorea
NCT05475483 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease
NCT06816810 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2